文献速递咽喉与嗓音头颈外科

小鼠HLA错配喉移植模型中免疫排斥的多维分析

Multidimensional Analysis of Immune Rejection in a Murine HLA-Mismatched Laryngeal Transplant Model.
PubMed 文献 · Laryngoscope · 2026-10-27

研究建立单HLA-A2错配的小鼠异位喉移植模型,并以同系移植为对照,整合生理、免疫与炎症指标动态评估排斥反应。结果显示单HLA I类错配即可驱动进行性免疫排斥和移植物损伤,移植物体积缩小在移植后1周即可检出。

要点

  • 单HLA-A2错配足以驱动小鼠喉移植进行性免疫排斥与移植物损伤。
  • 移植物体积缩小是移植后1周可检出的早期排斥判别指标。
  • CD4+与CD8+ T细胞自1周开始浸润,调节性T细胞3天升高后显著下降。

核心结论

  • 单HLA I类错配即可驱动喉移植进行性免疫排斥与移植物损伤。
  • 观察到一组与移植物不良结局相关的生物标志物,可作为HLA驱动免疫损伤的监测指标。

研究设计与样本

  • 将HLA-A2转基因小鼠喉移植物移植入C57BL/6受者,建立HLA错配喉移植模型。
  • 以C57BL/6→C57BL/6同系移植为对照。
  • 建立整合生理监测、免疫谱分析和炎症评估的多维评价体系,观察期为移植后第0天至12周。

主要发现

  • 与同系移植相比,HLA错配组免疫排斥和移植物损伤加重。
  • 移植物体积进行性缩小在移植后1周即可检出,与移植物表面变暗和溃疡相关。
  • 免疫表型分析显示CD4+和CD8+ T细胞浸润自1周开始,调节性T细胞在3天升高后显著下降。
  • 细胞因子谱显示MIP-1β、G-CSF和IL-10自4周起升高,与免疫激活和移植物损伤一致。

临床怎么用

  • 可将移植物体积缩小作为移植后1周早期识别排斥的监测指标。
  • 可结合CD4+/CD8+ T细胞浸润、调节性T细胞动态及MIP-1β、G-CSF、IL-10等指标监测HLA驱动免疫损伤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To establish a murine heterotopic laryngeal transplantation (LT) model with a single HLA-A2 mismatch and to develop a multidimensional framework for dynamic evaluation of immune rejection and graft injury. METHODS: Laryngeal grafts from HLA-A2 transgenic mice were transplanted into C57BL/6 recipients to generate an HLA-mismatched LT model, with syngeneic C57BL/6 → C57BL/6 transplants as controls. A multidimensional evaluation system was established, integrating physiological monitoring (survival, body weight, graft appearance, neck circumference, computed tomography, and ultrasonography), immunological profiling (histopathology, immunohistochemistry, and flow cytometry), and inflammatory assessments (cytokines and biochemical parameters) from Day 0 to 12 weeks posttransplantation. RESULTS: Compared with syngeneic transplantation, the HLA-mismatched group showed aggravated immune rejection and graft injury. Progressive graft volume reduction was an early discriminator, detectable at 1 week posttransplantation and correlating with graft surface darkening and ulceration. Immunophenotyping revealed early CD4+ and CD8+ T-cell infiltration beginning at 1 week, whereas regulatory T cells increased at 3 days before markedly declining. Cytokine profiling showed elevations of MIP-1β, G-CSF, and IL-10 from 4 weeks onward, consistent with immune activation and graft injury. CONCLUSION: A murine heterotopic LT model with an HLA-A2 mismatch was established, demonstrating that a single HLA Class I disparity was sufficient to drive progressive immune rejection and graft injury in LT. A panel of biomarkers associated with adverse graft outcomes was observed, providing indicators for monitoring HLA-driven immune injury. LEVEL OF EVIDENCE: N/A.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Song, Li, Wu, et al. Multidimensional Analysis of Immune Rejection in a Murine HLA-Mismatched Laryngeal Transplant Model. Laryngoscope. 2026. PMID: 42946397. doi:10.1002/lary.70987

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。